DuoCAR20.19.22-D95
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DuoCAR20.19.22-D95, covering 2025-04-06 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Evaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell Malignancies [Phase 1]